| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 21 |
| Opened positions | 3 |
| Closed positions | 4 |
| Increased positions | 0 |
| Reduced positions | 5 |
| 13F shares | Current |
|---|---|
| Total value | 12.67 bn |
| Total shares | 15.39 mm |
| Total puts | 2.40 k |
| Total calls | 26.00 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Decheng Capital | 4.96 mm | $11.35 bn |
| Ever Regal | 4.62 mm | $0.00 |
| Decheng Capital Management III | 1.98 mm | $4.30 mm |
| Decheng Capital China Life Sciences USD Fund III | 1.98 mm | $20.21 mm |
| Shenzhen Sangel Capital Management | 1.25 mm | $5.68 mm |
| C Citigroup | 250.00 k | $572.50 mm |
| BlackRock | 217.54 k | $498.16 mm |
| Tanaka Capital Management | 29.47 k | $67.00 k |
| Geode Capital Management | 24.37 k | $55.80 mm |
| NTRS Northern Trust | 16.70 k | $38.25 mm |
